JAKARTA, INDONESIA--(Marketwire - Oct 3, 2012) - Moments ago, [ DividendSeeker.net ] introduced new coverage of Abbott Laboratories (NYSE: [ ABT ]) and Glaxosmithkline Plc (NYSE: [ GSK ]). Full outlook, analysis and consensus opinion is available to readers via the links below.

[ www.DividendSeeker.net/r/forbes/05c1_ABT ]
[ www.DividendSeeker.net/r/forbes/2a35_GSK ]

The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include newly released third estimates of 1.3% for US second-quarter 2012 GDP growth notably below expectations of 1.7% (2nd estimate), smaller gains in non-residential construction as well as a slower build in business inventories and the recent rise in personal consumer expenditure (PCE) by 0.5% in August 2012 following July's 0.4% increase. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.

Dividend Seeker is releasing new coverage on Abbott Laboratories for its current position within the consumer durables sector. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. A copy of this report featuring Abbott Laboratories (NYSE: [ ABT ]) is available at: [ www.DividendSeeker.net/r/forbes/05c1_ABT ].

Dividend Seeker has released research on Glaxosmithkline Plc for its changing role within the consumer durables sector. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. To access the full research report on Glaxosmithkline Plc (NYSE: [ GSK ]) we welcome investors to visit: [ www.DividendSeeker.net/r/forbes/2a35_GSK ].

More About Dividend Seeker
For those looking to grow their portfolio and increase their net worth, Dividend Seeker is the right choice. Simplify your due diligence process and access investing tools and tips to head-start your investments. Join the community, subscribe to our newsletter and begin to experience the power of information. The more relevant data you have, the more opportunities you discover.